CA2427843A1 - Devices and methods for accessing and analyzing physiological fluid - Google Patents

Devices and methods for accessing and analyzing physiological fluid Download PDF

Info

Publication number
CA2427843A1
CA2427843A1 CA002427843A CA2427843A CA2427843A1 CA 2427843 A1 CA2427843 A1 CA 2427843A1 CA 002427843 A CA002427843 A CA 002427843A CA 2427843 A CA2427843 A CA 2427843A CA 2427843 A1 CA2427843 A1 CA 2427843A1
Authority
CA
Canada
Prior art keywords
skin
biosensor
cartridge
devices
piercing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002427843A
Other languages
French (fr)
Inventor
Borzu Sohrab
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LifeScan Inc
Original Assignee
LifeScan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29249849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2427843(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LifeScan Inc filed Critical LifeScan Inc
Publication of CA2427843A1 publication Critical patent/CA2427843A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15157Geometry of stocking means or arrangement of piercing elements therein
    • A61B5/15159Piercing elements stocked in or on a disc
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150213Venting means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150206Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
    • A61B5/150305Packages specially adapted for piercing devices or blood sampling devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150358Strips for collecting blood, e.g. absorbent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • A61B5/150419Pointed piercing elements, e.g. needles, lancets for piercing the skin comprising means for capillary action
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150442Blade-like piercing elements, e.g. blades, cutters, knives, for cutting the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150801Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming
    • A61B5/150809Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming by audible feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150801Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming
    • A61B5/150824Means for facilitating use, e.g. by people with impaired vision; means for indicating when used correctly or incorrectly; means for alarming by visual feedback
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150847Communication to or from blood sampling device
    • A61B5/150862Communication to or from blood sampling device intermediate range, e.g. within room or building
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150969Low-profile devices which resemble patches or plasters, e.g. also allowing collection of blood samples for testing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15126Means for controlling the lancing movement, e.g. 2D- or 3D-shaped elements, tooth-shaped elements or sliding guides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15146Devices loaded with multiple lancets simultaneously, e.g. for serial firing without reloading, for example by use of stocking means.
    • A61B5/15148Constructional features of stocking means, e.g. strip, roll, disc, cartridge, belt or tube
    • A61B5/15149Arrangement of piercing elements relative to each other
    • A61B5/15153Multiple piercing elements stocked in a single compartment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/157Devices characterised by integrated means for measuring characteristics of blood

Abstract

Systems, devices and methods for determining the concentration of physiological fluid analytes are provided. The subject systems have a plurality of biosensor devices present on a disposable cartridge. Each biosensor device includes a biosensor and a skin penetration means. In practicing the subject methods, a movement means of the device is used to move each biosensor device in a first direction that provides for penetration of the skin-piercing means into a skin layer followed by movement of the biosensor in a second direction that provides for removal of the skin-piercing means from the skin. layer, where this movement profile provides for physiological fluid access and analyte concentration determination by the analyte sensor means. The subject systems, devices and methods for using the same find use in determining the concentration of a variety of different physiological fluid analyzes, and are particularly suited for use in detection of physiological fluid glucose concentration.

Description

DEVICES ~NII 1VIETIIOI>S FOR ACCESShIG ANI3 ANALYZING I3HYSIOLOGICAL .FLLII) Fietd of the Invention [0001] The field of this invention is analyte concentration detection, particularly physiological fluid access and the determination of one or more analyte concentrations thereof.
Background of the Invention (0002] Analyte detection in physiological fluids, e.g., blood or blood derived products, physiologic4{I fluid, etc., is of ever increasing importance to today's society. Analyte detection assays find use in a variety of applications, including clinical laboratory testing, home testing, etc., where the results of such testing play a prominent role in diagnosis and management in a variety of disease conditions.
Analytes of interest include glucose for diabetes management, cholesterol, and the like. In response to this growing importance of analyte detection, a variety of analyte detection protc~eols and devices for both clinical and home use have been developed.
[0003] In determining the concentration of an analyte in a physiological sample, a physiological sample must first be obtained. Obtaining the sample often involves cumbersome and complicated devices which may not be easy to use or may be costly to manufacture. Furthermore, tl~e procedure for obtaining the sample may be painful. For example, pain is often associated with the size of the needle used to obtain the physiological sample and the depth to which the needle is inserted.
Depending on the anal:yte and the type of test employed, a relatively large, single needle or the Like is often used to extract the requisite amount of sample.
[0004] The analyte concentration determination process rnay also involve a multitude of steps. First, a sample is accessed by use of a skin-piercing mechanism, e.g., a needle or lancet, which accessing may also involve the use of a sample collection mechanism, e.g., a capillary tube. Next, the sample must then be transferred to a testing device, e.g., a test strip or the like, and then oftentimes the test strip is then transferred to a measuring device such as a meter.
Thus, the steps of accessing the sample, collecting the sample, transferring the sample to a biosensor, and measuring the analyze concentration in the sample are often performed as separate, consecutive steps with various device and instrumentation.
[0005] Because of these disadvantages, it is not uncommon for patients who require frequent monitoring of an analyte to simply become non-compliant in monitoring themselves. With diabetics, for example, the failure to measure their glucose level on a prescribed basis results in a lack of information necessary to properly control the level of glucose. Uncontrolled glucose levels can be very dangerous aid even life threatening.
[0006] Advances have been made in analyte detection technology to overcome the disadvantages of the above described testing protocols. .A primary advancement is the integration of the means for accessing physiological fluid and the means for testing the fluid for the presence andlor concentration of the analyte of interest, e.g., glucose. More specifically, such integrated devices include a biosensor having a skin-piercing element, such as a microneedle, integrated therewith.
Such exemplary devices are disclosed in, for example, the following U.S. Patent Applications: Serial Nos. 09/923,093; the application having Attorney Docket No.
LIFE-035, entitled "Physiological Sample Collection Devices and Methods of Using the Same" and filed on the same day herewith; the; application having Attorney Docket No. LIFE-058, entitled "Analyze Test I;lernent with Molded Lancing Blade" and filed on the same day herewith; and the application having Attorney Docket No. LIFE-073, entitled "Methods of Fabricating Physiological Sample Collection Devices" and filed on the same day herewith.
[0007 Despite such advancements, there is a continued interest in the development of new devices and methods for use in the detenminatian of analyte concentrations in a physiological sample. ~f particular interest would be the development of analyte concentration determination systems having integrated fluid accessing and testing functions, and methods of uses thereof, that are automated in order to minimize manipulation by the user, convenient, easy and and enhance portability.

Summary of the Inventiia~n [0008] Systems, devices and methods for accessing physiological fluid and deternuning the concentration of one or more analytes thereof. The subject systems provide a cartridge device containing a plurality of single-use biosensor/
skin-piercing/fluid access devices. The cartridge devices of the present invention have a flat or planar construct, and preferably have a disk shape but may have an elongated shape. The biosensor/skin-piercing/fluid access devices are provided within the cartridge in a serial configuration, preferably equally spaced from each other, parallel to a path along which the cartridge is caused to move or rotate. In disked shaped cartridges, such serial arrangement is about a circumference of the cartridge.
[0009] The subject systems further include a housing structure within which a cartridge is operatively loaded. The housing structure preferably has a skin-facing portion and/or surface which appositions a loaded cartridge loaded within to a section of the user's skin. The housing is preferably configured so as to be maintained against the skin for extended periods. To this end, the housing may have a "watchband" configuration to be worn on a limbic region, e.g., a wrist or forearm, of the user, or may have a configuration, such as a substantially planar configuration, for adhesive contact with a suitable location, e.g., torso, thigh, hip, etc., on the user's body.
[0010) Each biosensor/skin-piercing/fluid access device has a biosensor integrated with a skin-piercing or lancing element for piercing, cutting or lancing the skin and, in some embodiments, also includes a fluid collection channel or transfer pathway for transferaing the sampled physiological fluid within the skin to the biosensor portion of the device. The biosensors may hare an electrochenucal, photometric or colori.metric configuration by which to perform a measurement on the sampled fluid. Ir., some embodiments, the biosensor devices have a generally planar configuration wherein at least one skin-piercing member extends from the biosensor device. In certain of these embodiments, the skin-piercing .member extends substantially within the same plane as the planar biosensor device, while in other embodiments, the skin-piercing member extends in a direction substantially transverse to the planar confWuration of the biosensor device.
More specifically, in some embodiments, the biosensor devices are configured as test strips wherein the skin-piercing element extends from a member or component, e.g., a substrate, an electrode or spacer layer, of the test strip. Certain other embodiments provide a frame member having a planar configuration having a biosensor pad or strip and a micro-lancing element mounted on and integrated to the same planar surface, but are spaced apart frorr~ each other to facilitate the function of that particular device. In still other embodiments, an angled structure is provided which extends distally into at least one microneedle formation and which supports a biosensor chamber at a proximal end thereof.
[0011] The subject systems further include a meter housc;d within the housing structure for analyzin g the physiological fluid obtained by the biosensor/skin-piercingifluid access devices. Connectors or contacts are provided to operatively couple the biosensor devices with the meter whereby the meter provides the requisite signals to the biosensor devices to perform the assay measurement and includes means for determining the value of such measurement.
[0012] The subject system further provides means for operatively moving, e.g., advancing and reversing, a subject cartridge relative to an aperture a the housing structure for exposing and concealing an individual biosensor/skin-piercing/fluid access device through the aperture to an access site on the user's skin.
Alternately, at least a portion of the apertured housing structure is moveable to expose and unexposed an individual biosensor/skin-piercing/fluid access device. Such movement of the cartridge places the exposed biosensor devices in operative connection, via connectors and contacts, to the meter.
[0013] While the biosensor devices translate along with t:he cartridge device, in some embodiments, each biosensor device is operatively attached to the cartridge device so as to be movable relative to the cartridge device so as to optimize the angle by which the skin is to be pierced by the skin-piercing means, thereby reducing pain to the patient and trauma to the skin. Such movement involves deflection and/or rotation of a biosensor device about an axis which extends radially or perpendicular to the path through which the biosensors are caused to travel upon translation of the cartrid~7e device. T'he movement of the biosensor devices relative to the cartridge is primarily accomplished passively such as 'oy components fixed within the housing structure relative to the cartridge for advancing or deflecting each individual biosensor/skin-piercing/fIuid access device through the housing aperture towards an access site on the user, penetrating the access site with t:he skin-piercing element and then withdrawing or retracting the device fram the access site. Such components include but are not limited to ramp structures and clip mechanisms.
[0014] The subject systems may further include a controller, such as in the form of a microprocessor, for controlling the function of the meter and the movement of the cartridge and the biosensor devices, and for storing data related thereto.
The controller is programmable whereby the assay protocol and the timing thereof may be customized according to software algorithms. Such algorithms provided for the "continuous" monito3-ing of concentration of an analyte in a user, i.e., for automatically measuzing the concentration of an analyte in a user according to a predetez-mined scheduled, e.g., at two or more points over a given time period.
The systems may also provide for the user to implement an assay "on demand,"
thereby overriding the continuous monitoring protocol. ;such analyte concentration measurements are stored by the microprocessor or other memory storage means for immediate or later retrieval by the user or a physician. The subject systems may t~urther include a display means for displaying the results of the assay and other relevant infornnation. In cez~tain embodiments, such systems include means for communicating with exteznal devices for the transfer and receipt of information and data related to the assay results, the a:;say protocol, the user, the disposable cartridge, etc.
[0015] In practicing the subject methods, assay protocols are implement which involve accessing physiological fluid by piercing the user's skin with the skin-piercing element, collecting the accessed physiological fluid to within the biosensor and measuring the one or more target analytes within the physi~logical fluid. Each assay protocol involves the advancement or movement of the cartridge or an aperture associated therewith in a first direction that causes the skin-piercing element of an integrated biosensor device to penetrate the' skin, followed by movement of the cartridge or aperture in a second direction that provides for removal of the skin-piercing element from the skin, where this movement profrle provides for physiological fluid access and analyte concentration determination by the biosensor. Advancement of the cartridge or aperture may be performed manually by the user or driven by a motor controlled by the controller. Such advancement and skin-penetration may be done automatically according to a preprogrammed scheduled or at the will of the user.
[OOIb] The subject systems, devices and methods for using the same find use provide a repeatable fluid accessing and sampling interface between a biosensor and a target skin site for determining a chemical characteristic of the sampled fluid, typically, the concentration of a variety of different physiological fluid analytes, and most typically the concentration of glucose. The subject system and devices can be used in the continual measurement of an analyte of interest without the problems experienced with implantable analytc sensors. For example, because single-use substantialx.y painless analyte measurement means are employed, user irritation and pain are avoided. Furthermore, the individual measurement means employed need not be calibrated prior to use. In addition, with respect to the glucose the subject devices and methods can not only be employed to rapidly and accurately detect the occurrence of a hypo or hyperglycemic event without host participation or intervention, but they can also be employed to readily predict the occurrence of hypo and hyperglycemic conditions, and therefore provide for improved management of blood glucose metabolism associated disease conditions.
As such, the subject invention represents a significant contribution to the art.
[0017] These and other objects, advantages, and features of the invention will become apparent to those persons skilled in the art upon reading the details of the methods and systems of the present invention which are more fully described below.

Brief Bescription of the I~rawinQs [0018] Fig. 1A is an exploded view of an embodiment of an electrochemical biosensor/skin-piercing/fluid access device suitable for use with the cartridge devices and systems of the present invention. Fig. 1B is a perspective view of the assembled device of Fig. 1 A.
[0019] Fig. 2A is an exploded view of an embodiiment of a colorimetric or photometric biosensor/skin-piercing/fluid access device suitable for use with the cartridge devices and systems of the present invention. :Fig. 2B is a perspective view of the assembled device of Fig. 2A
[0020] Fig. 3 illustrates yet another embodiment of an electrochemical biosensorJskin-piercing/fiuid access device suitable for use with the cartridge devices and systems of the present invention.
[0021] Fig. 4 illustrates another embodiment of a.n electrochemical biosensor/skin-piercing/fluid access device suitable for use with the cartridge devices and systems of the present invention.
[0022] Fig. ~A illust:rates another embodiment of a biosc~nsorlskin-piercing/fluid access device suitable for use with the cartridge devices and systems of the present invention. Fig. 5B is a magnified view of the skin-piercing element of the device of Fig. 5A.
[0023] Fig. 6A is a top view of an embodiment of the system of the present invention having a user-friendly, portable configuration. Fig. 6B is a side view of the system of Fig. 6A, taken along lines B-B. Fig. 6C is a bottom view of the systems of Fig. 6B taken along lines C-C. Fig. 6l~ illustrates the system of Figs.
6A, 6B and 6C in an open condition, revealing a cartridge device of the present invention operatively positioned within the housing go the subject system.
[0024] Fig. 7A is a schematic representation of one embodiment of a cartridge device of the present invention. Fig. 7B is a view of an enlarged cut-away portion the cartridge device of Fig. '7A operatively engaged with a bottom portion of a system housing havirdg an embodiment of a biosensor movement means of the present invention.
[002j] Figs. 8A to 8F provide a schematic representation of one embodiment of a biosensor movement means of a system of the present invention and the step-by-step movement of a biosensor/skin-piercing/fluid access device of Figs. I, 2 or 3 on a cartridge of the present invention.
[0026] Figs. 9A to 9(.i provide a schematic representation of another embodiment of a biosensor movement means of a system of the present invention and the step-by-step movement of a biosensor/skin-piercing/fluid access device of Fig. 4 on a cartridge of the present invention.
(0027] Figs., 10A to I OC provide a schematic representation of the step-by-step movement of a cartridge of the present invention employed with the biosensor/
skin-piercing/fluid access device of Fig. 4.
[0028] Fig. 1 IA illustrates "wristband" embodiment of the subject system.
Fig.
I 1B illustrates a "waistband" embodiment of the subject system which is used with and in communication with a remote control device.
Dettailed Description ~f the Invention (0029] Before the present invention is described, it is to be understood that this invention is not limitf:d to the particular embodiments described, as such may, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular embodiments only, and is not intended to be limiting, since the scope of the present invention 'will be linuted only by the appended claims.
[0030] there a range of values is provided, it is understood that each intervening value, to the tenth of the unit of the lower limit unless the context clearly dictates otherwise, between the upper and lower Iimit of that range and any other stated or intervening value in that stated range is encompassed within the invention.
The upper and lower limit, of these smaller ranges may independently be included in the smaller ranges is also encompassed within the; invention, subject to any specifically excluded Iimit in the stated range. Where the stated range includes one or both of the Iin:uts, ranges excluding either or both of those included limits are also included in the invention.
[0031] Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill i.n the art to which this inventicm belongs. Although any methods and materials similar or equivalent to those described herein can also be used in the practice or testing of the present invention; the preferred methods and materials are now described.
[0032] It must be noted that as used herein and in the appended claims, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates other~Nise. Thus, for example, reference to "a test strip"
includes a plurality of such test strips and reference to "the device" includes reference to one or more devices and equivalents thereof known tc~ those .skilled in the art, and so forth.
[0033] The publications discussed herein are provided solely for their disclosure prior to the filing date of the present application. Nothing herein is to be construed as an admission that the present invention is not entitled to antedate such publication by virtue of prior invention. Further, the datca of publication provided may be different frorxi the actual publication dates. which may need to be independently confirmed.
[0034] The present invention will now be described in detail. In further describing the present invention, exemplary integrated biosensor/skin-piercing/fluid access devices suitable for use with the present invention are described first. Next, the subject systems and cartridge devices are described followed by a description of the various methods of using the subject systems and devices as well as methods for controlling the testing of physiological sample characaeristics will then be described. Finally, a brief description is provided of the subject kits, which kits include the subject cartridges andlor systems for use in practicing the subject methods.
[0035] In the following description, the present invention will be described in the context of analyte concentration measurement applications; however, such is not intended to be Iimitin,g and those skilled in the art will appreciate that the subject devices, systems and methods are useful in the measurement of other physical and chemical characteristics of biological substances, ~.g., blood coagulation time, blood cholesterol level, etc.
Exemplary _BiosensorlSkin-Piercina/Fluid Access Devicea [0036] Various different embodiments of biosensor/skin-piercing/fluid access devices (also referred to herein as biosensor devices) may be employed with the present invention. Biosensor/skin-piercing/fluid access devices suitable for use with the present invention typically have a biosensor component in the form of a test strip or pad, such as an electrochemical, colorimetric or photometric test strip, and have a skin-piercing component in the form of a microneedle or a micro-lancet. Referring now to Figs. 1A, 1B, 2A, 2B, 3, 4, 5A and 5B, there are shown such exemplary devices.
[0037] Figs. 1A and 1B illustrate such an exemplary biosensor device 2 which is disclosed in the copending U.S. Patent Application referenced above having Attorney Docket No. 035, herein incorporated by reference. Biosensor device 2 includes an electrochemical test strip configuration and a. microneedle 6 integrated therewith. The biosensor is defined by an electrochemical cell generally having two spaced-apart and opposing electrodes 3 and 5, respectively referred to herein as bottom electrode 3 and top electrode 5. At least the surfaces of electrodes 3 and facing each other are comprised of a conductive: layer 8 and 16, respectively, such as a metal, deposited on an inert substrate 4 and 18, respectively. The spacing between the t:wo elecarodes is a result of the presence of a spacer layer 12 positioned or sandwi<;hed between electrodes 3 and 5. Spacer layer 12 preferably has double-sided adhesive to hold electrodes 3 and 5 together. Spacer layer 12 is configured or cut so ~~s to provide a reaction zone or area 9. A redox reagent system or composition is present within reaction ;z,one 9, and specifically selected to interact with targeted components in the fluid sample during an assay of the sample. The redox reagent system is deposited on the conductive layer of top electrode 5 wherein, when in a completely assembled form (shown in Fig. 1B), the redox reagent system resides within reaction zone 9. ~lith such a configuration, bottom electrode 3 serves as a counter/reference electrode and top electrode 5 serves as the working electrode of the electrochemical cell. However, in other embodiments, depending an the voltage sequence applied to the cell, the role of the electrodes can be reversed such that bottom electrode 3 serves as a working electrode and top electrode 5 serves as a counter/reference electrode.
[0038] Microneedle 6 is integrally formed with and extends from and in the same plane as bottom electrode 3 and terminates distally in a sharp tapered tip 24 which facilitates penetration into the user's skin. Micron.eedle 6 further provides a space-defining configuration in the form of a concave recess 20 within its top surface.
Such recess creates a corresponding space within skin tissue upon penetration of microneedle'6 into the skin. This space acts as a sample fluid collection reservoir or pooling area wherein fluid released upon penetration i;a pooled within the space prior to transfer into the electrochemical cell. Optionally, microneedle 6 may further include an opening 22 in fluid communication wi9:h recess 2Q to facilitate the paoling rate of physiological fluid within the defined pooling area.
[0039] Biosensor device 2 further includes a sample fluid transfer or extraction pathway or channel 14) which extends from recess 20 to within the biosensor.
At least a portion of the proximal end 10a of the pathway resides within the biosensor portion of device 2, specifically within reaction zone 9, and a portion of distal end lOb of pathway 10 resides within microneedle 6. Pathway 10 is dimensioned so as to exert a capillary force on fluid within the pooling area defined by recess 20, and draws or wicks physiological sample to within reaction zone 9. Extending laterally from proximal portion 10a of pathway 10 to within a portion or the entirety of the reaction zone 9 are sub-channels 1'i. Sub-channels 15 facilitate the filling of reaction zone 9 with the sampled fluid.
[0040] Figs. 2A and 2B illustrate another suitable embodiment of a biosensor/skin-piercinglfluid access device 30 which is also disclosed in copending U.S. Patent Application having Attorney Docket No. LIFE-035.
Device 30 has a photometric/colorimetric biosensor configuration and a microneedle 32 integrated therewith. The colorirnetric or photometric biosensor is generally made up of at least the following components: a support element or substrate 34 made of a:ither an inert material, such as plastic, or a metal material, a 1i matrix area 36 for receiving a sample, a reagent composition (not shown as a structural component} within matrix area 36 that typically includes one or more members of an analyte; oxidation signal producing system, an air venting port (not shown) and a top layer 38 which covers at least matrix 36. In other embodiments, top layer 38 may be a membrane containing a reagent composition impregnated therein while the matrix area 36 may or may not contain reagent composition.
Further, test strip 30 has a double-sided adhesive layer 40 situated between substrate 34 and membrane 38 to hold them together. Double-sided adhesive layer 40 has a cut-,out portion 42 which corresponds to the area covered by matrix and defines an area for deposition of the sampled physiological fluid and for the various members of the signal producing system.
[0041] Microneedle i2 is formed with and extends from and in substantially the same plane as substraf:e 34 and has a space-defining confi juration in the form of an opening 44 which extends transverse to a dimer:~sion, e.g., width or thickness, of microneedle 32. As with recess 20 of microneedle 6 above, opening 44 forms an open space within the tissue upon penetration of microneedle 32 into the skin.
Such open space acts as a sample fluid collection reservoir wherein fluid released upon penetration is pooled within the space prior to transfer into the photometrielcolorimetric cell.
[0042] Biosensor device 30 hosts a sample fluid transfer or extraction pathway having a distal end 46b which extends within a portion of microneedle 32 and terminates at a distal opening 48. At least a portion of the proximal end 46a of pathway 46 resides within the biosensor portion of device 30, specifically within matrix area 36. Pathway 48 is dimensioned so as to exert a capill-ary force on fluid within the pooling area defined by opening 44, and draws or wicks physiological sample to within matrix area 36. Extending laterally from proximal portion 46a of pathway 46 to within a portion or the entirety of matr~ax area 36 are sub-channels 50, which facilitate the filling of matrix area 36 with the sampled fluid.
[0043] Fig. 3 illustrates another exemplary bioserzsor device 60, disclosed in copending U.S. Patent Application Serial Ihllo. 09/923,093, herein incorporated by reference, which is suitable for use with the presen;?t invention. Device 60 has an iz electrochemical test strip configuration similar to device 2 of Figs. 1A and 1B, having a first electrode 62 with an associated inert substrate 64, a second electrode 66 with an associated inert substrate 68 and a spacer layer 70 there between which, collectively, form a reaction zone 72 having an appropriate redox reagent system.
Instead of a single rnicroneedle extending from an electrode or substrate thereaf, as described with respect to the devices of Figs. 1 and 2, device 60 has a plurality of skin-piercing elements 74 extending from and in substantially the same plane as spacer layer 70. Skin-piercing elements 74 may be made of the same material as spacer layer 70 or of a different material. Skin-piercing elements 74 each have a fluid channel 76 which extends proximally into spacer layer 70 to reaction zone 72. Each fluid channel 76 is open to the outside environment along a substantial length of a first side 78 and a second side 80 of the respective skin-piercing element and terminates proximal to distal tip 82 of the skin-piercing element 74.
Channels 76 are dimensioned to exert a capillary force for collecting and transferring physiological sample aceessed by the skin-piercing element 74.
While each skin-piercing element is illustrated having a single fluid pathway 76, a plurality of such pathways may be used in each skin-piercing element 74.
[0044] Fig. 4 illustrates another suitable embodiment of a biosensor/skin-piercing/fluid access device 90 having an angled structure. Device 90 includes two piercing/fluid sampling rnicroneedles 92, each including a. flow pathway extending from a distal opening 94 to a reaction zone or matrix area 100 of a proximal biosensor 98. The angled structures are typically elongated structures characterized by the presence of a single bend located proximal to the center of the elongated structure. The number of skin piercing structures, and thus the number of flow pathways, may vary, typically ranging from about 1 to 5, usually from about 1 to 4 and more usually from about 1 to 3, where the number of piercing elements typically ranges from 1 to 2 in many ernbodiments. The angle of the single bend typically ranges from about 135° to 150° and more usually from about 140° to 145°. The length from the bend to the very tip of the elongated angular structures typically ranges from about 2.3 to 3.2 um and more usually from about 2.6 to 3Ø

[0045] The fluid flow pathways 96 have capillary dimensions that result in capillary flow of accessed physiological fluid from the distal openings 94 along the length of the flow pathway to the biosensor 98. As the flow path is one that has capillary dimensions, the flow path typically has a diameter at any point along its length in the range from about 80 to 150 ~,m. The flow path may be tubular or have some other configuration, e.g., one that provides for a cross-sectional shape that is a square, rectangle, oval, star, etc., where the configuration of the flow path is not critical so long as it provides for the desired capillary flow.
[0046] Bios~nsor 98 typically is made up of a sensor chamber that includes a transducing means which produces a signal in response to the presence, and typically concentration of, analyte in physiological fluid present in the chamber.
The chamber located at the proximal end of device 90 typically has a volume in the range from about 100 to 300 uL. The transducing means may be any convenient transducing means that is capable of generating a signal in response to the presence of analyze in fluid present in the chamber. while in the broadest sense the transducing means may produce a signal that is indicative of the presence of, analyze, in many preferred embodiments, the transducing means is one that generates a signal that is proportional to the amount of analyte in the physiological fluid.
[0047] ~ne type of transducing means of interest that may be present in the subject sensors is a photometric transducing means. Photometric transducing means of interest typically include one or more reagents of a signal producing system that produces a detectable product in proportion to the amount of analyte present in the chamber. The detectable product is then photometrically detected to provide for a detection of the presence of analyte, and typically a measurement of the concentration of analyze, that is present in the fluid inside the chamber.
Photometric transduction means of interest that may be employed in such biosensor devices include, but are not linuted to, those described in LT.S.
Patent Nos. 4,935,346; 5,049,487; 5,509,394; 5,179,005; 5,304,468; 5,426,032;
5,563,042; 5,843,692; and 5,968,760; the disclosures of which are herein incorporated by reference.

[0048) Another type of transducing means of interest that may be present in the subject sensors is an electrochemical transducing means. Electrochemical transducing means of interest typically include an electrochemical cell that includes two electrodes and one or mare reagents of signal producing system, where these elements work in concert to produce an electrical current in proportion to the amount of ariaiyte present in the chamber. 'The generated electrical current provides for a detection of the presence of analyte, and typically a measurement of the concentration of, analyte that is present in the fluid inside the chamber., Electrochemical transduction means of interest that may be employed in~the biosensor devices include, but are not limited to, those described in U.S. Patent Nos. 5,834,224; 5,942,102; and 5,972,199; as well as 1.1.5.
Patent Application Serial Nos. 09/333,793; 09/497,269 and 09/497,304; the disclosures of which are herein incorporated by reference.
[0049) Figs. 5A and 5B illustrate another exemplary embodiment of a biosensor/skin-piercing/fluid access device 110 suitable for use with the present invention, which device is disclosed in the copen.ding U.S. Patent Application the referenced above having Attorney locket No. 058, herein incorporated by reference. Device 110 includes a planar frame 112, and a blade portion 114 and a sensor portion 116 mounted on and carried by frame 1 I2. Blade portion 114 includes an intermediate wedge or raiser member 118 upon which is mounted a blade or lancing element 120 which extends substantially transverse to planar frame 112. Member 118 serves to elevate blade or Lancing element 120 relative to a skin-facing surface or face 122 of frame 112. raiser member 118 has an angled front surface or ramp portion 124 which allows for smooth translational movement of device 110 relative to the skin of the user. A landing area 126 is provided upon which blade 120 is specifically mounted, the narrow construct of which acts to reduce frictional forces with the user's skin while increasing the ability to compress tissue riding over the structure. Blade I20 is provided with a triangular shape having a larger base and substantially vertical side portions, however, blade 120 may have any shape whose geometry is robust enough to avoid break-off.
Sensor portion 11~ is spaced apart from blade portion 114 to allow substantially flush engagement by sensor portion 116 with the cut area of the user's skin.
Sensor portion 116 provides a sensor pad or area 128 for receiving the access physiological fluid, i.e., interstitial fluid or blood. Sensor pad 128 may have either an electrochemical or photometric configuration as described above.
[0050] While specific configurations of biosensor/skin-piercing/fluid access devices suitable for use with the systems of the present invention have been illustrated and described, it is understood that any type of biosensor, e.g., electrochemical, photometric, colorimetric, may be employed with one or more suitable skin,-piercing elements or microneedles. Additionally, while specific shapes of skin-piercing elements and microneedles have been illustrated and described, any suitable shape of skin-piercing element may be employed with the biosensor devices, as long as the shape enables the skin to be pierced with minimal pain to the patient. For example, the skin-piercing element may have a substantially flat or planar configuration, or may be substantially cylindrical-like, wedge-like or triangular in shape such as a substantially flattened triangle-like configuration, blade-shaped, or have any other suitable shape. The cross-sectional shape of the skin-piercing element, or at least the portion of skin-piercing element that is penetrable into the skin, may be any suitable shape, including, but not limited to, substantially rectangular, oblong, square, oval, circular, diamond, triangular, star, etc. Additionally, the skin-piercing element may be tapered or may otherwise define a point or apex at its distal end. Such a configuration may take the form of a.n oblique angle at the tip or a pyramid or triangular shape or the like. The dimensions of the skin-piercing element may vary depending on a variety of factors such as the type of physiological sample to be obtained, the desired penetration depth and the thickness of the skin layers of the particular patient being tested. Generally, the skin-piercing element is constructed to provide skin-piercing and fluid extraction functions and, thus, is designed to be sufficiently robust to withstand insertion into and withdrawal from the skin.
[0051] In each embodiment, the biosensor/skin-piercing/fluid access devices are configured so as to provide a repeatable interface with the physiological fluid access site and with the target skin layer when operatively employed with the cartridge devices and systems of the present invention, which are now described in detail.
Systems of the Present Invention [0052 Referring to Figs. 6A, 6B, 6C and 6D, there is illustrated a physiological sample collection and measurement system 200 of the present invention having a compact, portable structural configuration. This structure includes an ergonomic housing 202 having a top portion 204 and a bottom portion 206 hinged together by hinge means, 208 which allows top and bottom portions 204 and 206 to be opened apart and closed upon manual activation of depressible key 226 or the like.
Fig.
6D illustrates housing 202 in such an open condition while Figs. 6A, 6B and 6C
illustrate housing 202 in a closed condition. Together, top housing portion and bottom housing portion 206 define an interior compartment into which a cartridge device 210 of the present invention is operatively loaded and then removed after use. As will be described in greater detail below with respect to Figs. 7A and 7B, cartridge 2I0 contains or provides one or more, and typically a plurality of, biosensor/fluid access devices 220.
j0053] When properly loaded within the interior compartment of the housing, the bottom surface of cartridge device 210 is positioned adjacent the internal side of a bottom wall 212 of bottom housing portion 206. Preferably, bottom wall 212 has an external surface configuration which is smooth and contoured as necessary to be flush against a selected area of the user's skin. Within bottom wall 212 is an aperture 214, as shown in Fig. 6C, sized and positioned such that a single biosensor/fluid access device 220 may be aligned with and exposed through aperture 214 while the remaining biosensor/fluid access devices 220 are concealed and protected within bottom wall 210. Associated with aperture 214 are contact means (not shown), e.g., electrical Ieads or an analogous means, for communicating electrical signals between device 220 when positioned at aperture 214 with a meter or measurement means (not shown) housed within housing 202.
Such electrical signals include input signals from the meter to the device 220 for initiating the chemical reaction between a sampled fluid and a reagent within device 220 in order to determine a chemical characteristic, e.g., analyze (e.g., Glucose) concentration, of fluid accessed and sampled from the user's skin by means of a device 220.
[0054] Such measurement means has the necessary construct and components for compatibility with the type of biosensor employed on devices 220, e.g., an electrochemical, photometric or colorimetric sensor. With an electrochemical based measurement system, the electrochemical measurement that is made may vary depending on the type of assay measurement and the meter employed, e.g., depending o~ whether the assay is coulometric, amperometric or potentiometric.
Generally, the electrochemical measurement will measure charge (coulometric), current (amperometric) or potential (potentiometric), usually over a given period of time following sample introduction into the reaction area. Methods for making the above described electrochemical measurement are further described in U.S.
Patent Nos.: 4,224,125; 4,545,382; and 5,266,179; as well as in International Patent Publications WO 97/18465 and WO 99/49307; the disclosures of which are herein incorporated by reference. With photometric/colorimetric assays, optical-type meters are used to perform the assay. Such assays and methods and instruments for performing the same, are further described in U.S. Patent Nos.
4,734,360; 4,900,666; 4,935,346; 5,059,394; 5,304,468; 5,306,623; 5,418,142;
5,426,032; 5,515,170; 5,526,120; 5,563,042; 5,620,863; 5,753,429; 5,773,452;
5,780,304; 5,789,255; 5,843,691; 5,846,486; 5,968,836 and 5,972,294; the disci~sures of which are herein incorporated by reference.
[0055] System 200 further includes means for operatively moving cartridge 210 within housing 202 so as to operatively move cartridge 210 in order to sequentially position each biosensor/fluid access device 220 at or relative to aperture 214. Such cartridge movement involves advancement of cartridge 210 in one direction, e.g., clockwise, and reversal of cartridge 2I0 in the opposite direction, e.g., counter clockwise, relative to aperture 214 to align a device within aperture 214 and to remove or conceal a device 220 from aperture 214.
Such cartridge movement means may be a motor-driven system, or the like, or may be manually driven by the user by means of a ring or lever mechanism external to housing 202. In a motor-driven system, cartridge 210 may be provided with a drive wheel 232 such that, when cartridge device 210 is operatively loaded and positioned within housing 202, drive wheel 232 is engaged with a drive shaft 234 for rotating cartridge 210 in forward and reverse directions. Drive shaft 234 is in turn rotated by a drive motor, also located within compartment 230.
[0056] System 200 also includes biosensor movement means (not shown) associated with cartridge 210 at aperture 214 for applying a force on each device 220 that is positioned at aperture 214. Such biosensor movement means moves a device 220 downward from the bottom surface of the cartridge on which all of the devices 220 are positioned, and through aperture 214 so as to operatively contact device 220 with the selected skin area. Such operative contact involves piercing, cutting or lancing the skin surface with a skin-piercing element provided on each device 220. Any convenient means for applying such downward force on a device 220 may be employed, where representative means include spring means or analogous mechanical means, and the like, which are described in greater detail below.
[0057] System 200 further includes a controller having a microprocessor for controlling operation of the measurement means., data processing means, automated cartridge movement means, and a display 218 for displaying measurement data and other related data, e.g., to inform the user when all of the devices 220 have been used. T'he microprocessor may further be associated with a memory storage means for the short-term or long-term storage of measurement data. System 200 may further include a conumunication module for the bidirectional communication with a remote control device or and other devices, e.g., by wireless data communication means, e.g., telemetry means, such as by infrared (IR) transmission or radio frequency (R.~) transmission, for the communication of assay protocol programs and information and for the immediate or later retrieval of measurement data and the like. System 200 further provides user control keys 224 on housing 202 to allow the user to enter or select data or parameters from menus displayed on the display, or to activate movement of the cartridge and an assay protocol, which representative data signals are sent to the m system controller. System 200 may further control visual and audible alarms which alert the user when it is time for an assay to be performed. when a cartridge needs replacing, when an analyte measurement is outside of safe range, etc. A
power supply and a battery are also provided to supply electrical power to the cartridge motor, the microprocessor and all components controlled by the microprocessor.
[0058] The system components just described may be housed in a protective, sealed compartment 230 wherein the necessary data or signal lines may run, for example, from compartment 230 in top housing portion 204 through hinge 208 to bottom housing portion 206. Alternately, such data or signal lines may be provided within top housing portion 204 such that they come into contact with corresponding data or signal lines within bottom housing portion 306 when the housing is in a closed condition.
[0059] Referring now to Fig. 7A, there is shown a representation of one embodiment of a cartridge device 300 of the present invention suitable for use with at Ieast the biosensor/skin-piercing/fluid access devices of Figs. l, 2 and 3.
Cartridge device 300 has a cartridge body or frame 302 and a plurality of integrated biosensor/skin-piercing/fluid access devices 304 (also referred to herein as biosensor devices) positioned thereon, preferably in a serial arrangement wherein devices 304 are evenly spaced apart from each other. The cartridges of the present invention may host any suitable number of integrated biosensor devices 304 wherein the number of cartridges generally ranges from about 6 to 10.
[OObO] In the annular or disk configuration of Fig. 7A, cartridge body 302 is defined by concentric frame rings, outer frame ring 302a and inner frame ring 302b. Rings 302a and 302b are fixed relative to each other by means of a plurality of torsion bars 306 which extend between rings 302a and 302b. Frame 304 is made of any rigid material such as injection molded plastic such as a polycarbonate material, while torsion bars 306 are preferably made of a material having properties and/or dimensions so as to be flexible or twistable about their longitudinal axis, e.g., stainless steel bars having a thickness in the range from about 50 to 75 ~,m and a width in the range from about 0.5 to 1 mm. Each integrated biosensor devices 304 is operatively attached to a torsion bar 306, preferably wherein there is a one-to-one correspondence between devices 304 and torsion bars 306. Each torsion bar 306 allows the corresponding attached device to rotate relative to frame 304 at Least partially about the longitudinal axis defined by the torsion bar. As such, this axis of rotation is perpendicular to a path along which cartridge 300 is caused to rotate or travel. Cartridge 300 typically has a diameter ranging from about 3 to 4 cm, where the distance between the center of the disk and the biosensor devices typically ranges from about 7 to 9 mm.
[006] As mentioned above, cartridge device 300 may further include a drive wheel 308 for attachment to a drive shaft housed within system 200 in which the cartridge device 300 is to be loaded. Alternatively, drive wheel 308 may also be separately housed within the system housing and be configured to receive and engage with cartridge frame 302. Drive wheel 308 includes a hub 310 and a plurality of frame bars 312 fixed to inner frame ring 302b. Rotation of drive wheel 308 causes rotational translation of cartridge body 302 and, thus, rotational translation of devices 304 about hub 310.
[0062] Fig. 7B illustrates a cut-away portion of cartridge device 300 operatively positioned within a bottom housing portion 314 of a subject system having an aperture 316. The width of aperture 316 is sufficient for the biosensor devices 316 to pass through, and typically ranges from about 3 to 8 mm and usually from about 4 to 6 mm. Components 320a and 320b of a biosensor rnovement means are operatively fixed within the system housing and located proximate a forward side 318a and a reverse side 318b of aperture 316, respectively. Component 320a has a wedged configuration and component 320b has a spring-loaded clip configuration.
As best seen in Figs. 8A-F, biosensor movement component 320a has a top planar surface 322 and a downward sloping front surface 324, while biosensor movement component 320b has a top clip member 326 spring-loaded or biased against a bottom clip member 328. Component 320a is positioned on bottom housing portion 3I4 and under cartridge device 300 while component 320b is positioned such that the plane in which cartridge device 300 and biosensor devices 304 rotate passes between clip members 326 and 328.

[0063] The movement underdone by a biosensor 304a throughout an assay application is now described with reference to Figs. 8A-F. Cartridge device 300, when inactive, is preferably positioned such that aperture 316 is free and clear of biosensor devices 304 so as to prevent contamination of the biosensor devices and inadvertent injury to the user. Furthermore, each device 304 is maintained in a substantially planar position relative to bottom housing portion 314 by means of the tension placed on the devices 304 by torsion bars 306. Advancing or rotating cartridge device in the direction of arrow 330, i.e.., in a counter clockwise direction with reference to Fig. 7B, will cause biosensor device 304a to advance or rotate in the same direction thereby approaching component 320b. As device 304a is advanced, it is caused to wedge between top clip 326 and bottom clip 328b (see Fig. 8A). As the clip members are biased against each other, biosensor device 304a is in frictional contact with component 320b when positioned between the clip members 326 and 328. When biosensor device 304a is sufficiently advanced in the direction of arrow 332 such that its back or proximal end 334 is between clip members 326 and 328, component 320b places a slight upward force or pressure on biosensor device 304a thereby causing device 304a to rotate about torsion bar 306 and front or needle end 336 of device 304a to deflect downward toward aperture 316 (see Fig. 8B). As device 304a is advanced further forward, in the direction of arrow 338, deflected front end 336 is caused to contact sloped front surface 324 of wedged component 320a (see Fig. 8C), thereby being further forced or deflected in a downward and forward direction. At this point; such deflection and forward motion is sufficient to cause the skin-piercing element of device 304a to pierce the target skin surface of the user (not shown).
During such piercing, physiological fluid, e.g ., interstitial fluid or blood, is accessed and drawn up into the biosensor portion of device 304a for testing by the system's measurement componentry. After sufficient time for accessing and collecting a sample of physiological fluid has passed, the cartridge device 300 is caused to move in a reverse direction 342, e.g., in a clockwise direction, (see Fig. 8D) until device 304a becomes disengaged from movement components 320a and 320b and is caused by torsion bar 306 to return to its original planar position relative to cartridge rings 302a and 3026 (see Fig. 8E). Finally, cartridge 300 is a~.~ain advanced in a forward direction 346 until used device 304a completely passes over aperture 3I6 of Fig. 7B (see Fig. 8F), at which point cartridge 300 may be locked in place so as to prevent inadvertent movement and possible injury to the user.
Such process is repeated with each device 304 when an assay protocol is activated by the user. When alI devices 304 are used, i. e., have been employed to perform an assay protocol, the used cartridge may be removed from the system's housing and properly disposed of. A replacement cartridge may then be loaded into the system. .
[0064] Referring now to Figs. 9A-9G, there is shown another embodiment of a biosensor movement means 400, particularly suited for use with the biosensor/
skin-piercing/access devices of Fig. 4. The biosensor movement means 400 includes spaced-apart components 402a and 4026 present within the housing of the subject systems. components 402a and 4026 are spaced apart so as to straddle an aperture 40I within the bottom housing wall, as described above, and provide surfaces and edges to guide a biosensor device 404 through aperture 401 for operatively contacting a target skin surface area of a user. Such surfaces and edges match the slope of the surfaces and the angles of the edges of biosensor device 404. More specifically, component 402a has an angled surface 410 that matches the back surface 412 of angled biosensor device 404. Angled surface typically forms an angle cc with the bottom surface 414 of component 402a that ranges from about 40° to 55°, and more usually from about 45° to 50°:
Furthermore, component 4026 has a top surface 406 that engages a bottom surface 408 of the angled biosensor device 404, and has an angled back surface 416 that matches a front surface 418 of angled biosensor device 404. Angled back surface 416 typically forms an angle ~ with the bottom surface 420 of component 4026 that ranges from about 30° to 50° and more usually from about 25° to 35°.
[006j] The movement undergone by biosensor device 404 throughout an assay application is now described with reference to Figs. 9A-9G. As with the embodiment described with respect to Figs. 7A and 7B, biosensor device 404 may be operatively attached to a cartridge (not shown) by way of a tension bar (not shown) or by way of a rotational pivot attachment to a hublspoke (see Figs.
l0A-lOC) such that biosensor device 404 is held in an. original biased position in which bottom surface 408 of device 404 is flush with top surface 406 of component 402b. In Fig. 9A, angled biosensor 404 is moved in a first direction according to arrow 422, across top surface 406 of component 402b. Fig. 9B shows that as the angled biosensor 404 is moved across the spacing between components 402a and 402b in the direction of arrow 424, it drops down into the opening there between, moving along sloped surface 410 of component 402a. At this point, the direction of travel of angled biosensor 404 is reversed, as shown in Fig. 9C; in the forward direction indicated by arrow 426. Because of the downward force applied by the cartridge, angled biosensor 404 continues to move downward along sloped surface 410 such that bottom surface 408 of angled biosensor 404 becomes flush with a targeted skin surface exposed through aperture 401. Continued forward movement of angled sensor 10, in the direction of arrow 428 (see Fig. 9D), brings front surface 418 of angled biosensor 404 into contact with inversely sloped surface of component 402b. This contact forces biosensor 404 further downward and into the skin surface to the target skin surface, causing the skin-piercing configurations 430 of biosensor 404 to penetrate the target skin surface to selected skin layer, e.g., the dermis, epidermis, subdermis, etc., thereby accessing the physiological fluid of interest, e.g., interstitial fluid or blood, ~rhich fills the capillary flow path of biosensor 404.
[0066] Following sampling and fluid fill of the capillary flow path of biosensor 404, biosensor 404 is again moved in the first direction as shown in Fig. 9E
according to arrow 432. Continued movement of biosensor 404 in the first, reverse direction causes removal of biosensor 404 from the skin surface/sampling site and brings biosensor 404 up, out of the opening between components 402a and 402b, as shown in Fig. 9F and indicated by arrow 434. Qnce the angled sensor is brought out of the opening, as shown in Fig. 9G, the fluid present in the biosensor chamber can be assayed. (4f course, where desired the fluid can be assayed while the sensor is still in situ, depending on the preferred sampling/measurement protocol being employed.) Such process is repeated with each biosensor device 404 when an assay protocol is activated by the user.
When all devices 404 are used, i.e., have been employed to perform an assay protocol, the used cartridge may be removed from the system's housing and properly disposed of. A replacement cartridge may then be loaded into the system.
[0067) The cartridge movement means of the embodiment described with respect to Figs. 4 and 9 is further illustrated in terms of a representative rotary cartridge device as shown in Figs. 10A to IOC. In Fig. 10A, rotary or disk cartridge 440 includes 8 individual angled biosensors 442 and is positioned on top of bottom surface 444 of housing (not shown) having an aperture 446 therein. In use, cartridge 44b rotates in a first clockwise direction 448 as shown in Fig. 10A
to operatively position a biosensor 442 relative to the biosensor movement means according to Figs. 9A and 9B. The direction of the cartridge rotation is then reversed to a counter-clockwise direction 450 as shown in Fig. 10B, which brings the biosensor 442a into the aperture 446 within bottom surface 444 wherein the target skin surface area is pierced and physiological fluid is accessed an transported to the chamber of biosensor 442a. Then, the direction of rotation of cartridge 440 is again reversed to a clockwise direction 4S2 as shown in Fig.
IOC, which withdraws biosensor 442a out of the skin, followed by subsequent measurement of analyte in the accessed fluid.
[0068] With minor modifications understood by those skilled in the art, the biosensor conf guration described above with respect to Fig. 5 may be similarly employed with the cartridge embodiments of Figs. 7 and 8 or of Figs. 9 and 10 and their respective cartridge and biosensor movement means. As such, the cartridge as well as the corresponding construct of the subject system may be configured in a number of different ways, so long as the cartridge device can be manipulated in a forward and reverse direction for performing the assay protocol, and as along as the biosensor devices can be operatively manipulated the biosensor movement means of the system so that the biosensor devices present on the cartridge can pierce the skin surface and access the physiological fluid therein.
[0069] The device and systems may take a variety of different configurations.
In certain embodiments, the devices are single internal devices, in which the measurement meaccs, processing means, display means etc. are all present on the same structure. In yet other embodiments, one or mare of the components may be separate from the other components. For example, the measurement means may be separated from the display means, where telemetric communication or analysis data transmission means, e.g., radio frequency or RF means, are employed to provide for data communication between the two or more disparate components of the device.
[0070] ~ne representative subject system embodiment is a "watchband".
embodiment as shown in Fig. I 1A, in which thf: device 500 is configured to be worn around' a limbic portion 502, ~,~.g., a forearm, in a manner analogous to a watch. In this embodiment, all of the components of the device may be present in one integral unit, where the unit is maintained in contact with the skin of the host via an adjustable strap 50~. or other retention means.
[007I] Where it is desirable to have a subject system in contact with a portion of the user that is not readily viewable, e.g., a portion of the waste or other portion that is typically covered by clothes or otherwise not readily viewable, a two component system, as shown in Fig. I IB, may be employed. With such an embodiment, the cartridge device and measurement means, a.e., the biosensors and meter, are present vrithin one component, e.g., a "waistband" component 506, and the display and conr:rol means are present on a second component of the system, e.g., a hand-held, remote control unit 508. The two components communicate with each other a data communication means, where the data communication means is typically a wireless data communication means, e.g., RF telemetric means.
[0072] In other embodiments of the present invention, the subject systems do not require a band or strap for attachment, but instead, may be attached to an appropriate skin area by means of a biocompatible adhesive.
Methods of the Present Invention [0073] The subject systems and devices find use: in methods of determining a characteristic of physiological fluid, most typically, measuring the concentration of an analyte in a physiological fluid.. In practicing the subject methods, a device having an integrated biosensor and skin-piercing element, such as the various embodiments described above, is provided and positioned relative to a target skin surface area of the user. The integrated biosensor device is caused to move or translate from an initial or retracted position to a. second, extended or skin-contacting position skin wherein the target surface is pierced, and physiological fluid is accessed anti transported to the biosensor portion of the device. The translation or movement of the device is reversed to remove and retract it from the 5kln.
[0074] When used with the subject cartridge devices described above, a plurality of such integrated biosensor devices is provided in operative engagement with the cartridge device. The cartridge device is provided and positioned planar to a target skin surface area of the user. A movement means is employed to move or translate the cartridge in a first direction which acts to move or translate the biosensor device from an initial or retracted position to a second, extended or skin-contacting position 'wherein the target surface is pierced, physiological fluid is accessed and transported to the biosensor portion of the device. The movement means is then activ«ted to move or translate the cartridge device in a second or reverse direction which acts to move or translate the biosensor from this second, extended position back to a retracted position. ~>uch movement of the biosensor device from a retracted to a skin-contacting position, and visa versa, may be further defined by deflecting the biosensor devia.e from a substantially planar position to angled or deflected position for contacting and piercing the skin.
[0075] When used avith the subject system as described above, the cartridge device is provided within or loaded into a housing structure having a skin-facing wall having an aperture therein. The external surface of the skin-facing wall is preferably positioned flush with the targeted skin surface area of the user.
The cartridge device is positioned within housing structure such that it is planar with the skin facing surface and wherein the translation of the plurality of biosensor devices is in a pathway directly over the aperture. l.Tpon movement or translation of the cartridge as described above, the movement or deflection of a particular biosensor device involves passage of at least the skin-piercing element through the aperture to contact and pierce the skin surface.
[0076] The subject methods further include providing a meter or measurement means as described above in operative contact wiah the biosensor device for measuring the selected characteristic of the sampled physiological fluid transferred to the biosensor device upon accessing the physiological fluid. Upon filling of the reaction zone or matrix area of the biosensor device with the sampled physiological fluid, a signal is applied to the biosensor try the meter componentry of the subject systerr~, and the chemical characteristic of interest, e.g., analyte concentratian, is made and the resulting measurement data is displayed via a display provided on the system housing and is stored into memory for immediate or later retrieval.
[0077 The subject methods, devices and systems find use in a variety of different applications in which detection of an analyte and/or measurement of anal;yte concentration in a physiological fluid is desired. The subject systems, devices and methods find particu.Iar use in analyte concentration monitoring applications over a given period of time, as described in copending U.S. Patent Application Serial No. 09/865,826, the disclosure of which is herein incorporated by reference, where the physiological fluid sampling/measurement occurs automatically and continuously according to a predetermined schedule.
[0078 In these monitoring applications, the present invention may be employed to: (a) continuously monitor an analyze whose concentration is associated with a disease condition, e.g., hypo-or hyperglycemia in blood sugar disorders such as diabetes; (b) continuously monitor an analyte whose concentration is associated with a non-disease physiological condition of interest, e.g., alcohol intoxication, illegal drug use; (c) continuously monitor the concentration of a therapeutic agent in drug therapy applications; etc.
[0079] Where the analyte is glucose, the present: invention finds use in a variety of different applications relating to the treatment and management of glucose associated disease conditions, e.g., diabetes and related conditions. In these embodiments, the subject methods and devices find use in providing for "continual" glucose monitoring, by which is meant that glucose levels in a patient are measured intermittently and automatically according to a predetermined schedule. The subject methods can also be employed to detect and predict the occurrence of hypo- and hyperglycemic conditions. In such applications, the pattern of continually monitored analyze concentration measurements can be employed to determine whether a patient is experiencing hyper- or hypoglycenua by comparing the pattern of measurement results stored within the systems memory storage means to a control or reference pattern. In addition, one can look at a pattern Qf measurements and compare it to an appropriate control or reference pattern to predict the occurrence of a hypo or hyperglycemic condition. The subject methods can be part of a more comprehensive therapy protocol designed to prevent the occurrence of hypo and hyperglycemic events, e.g., by predicting the occurrence of such events with the subject methods and device and intervening in blood sugar metabolism in a manner that prevents the occurrence of the predicted event.
[0080] The present invention may be employed with a variety of different types of hosts where analyte monitoring is desired. Hosts of interest include, but are not limited to mammals. Mammals of interest include valuable livestock, e.g., horses, cows, sheeps, etc., pets, e.g., dogs, cats etc., and humans. In most embodiments, the mammals on which the subject methods are practiced are humans.
Kits [0081] Also provided are kits for practicing the subject methods. In one embodiment, the kits include a system for practicing the subject invention.
The system may be a single integral device or made up of two or more disparate components, e.g., a remote-control and display component and a measurement component. The kits may include a single disposable cartridge device, or two or more disposable cartridges devices, as described above for use with the subject system. Finally, the kits typically include instructions for using the subject systems and for loading and removing cartridges into and out of the subject system. These instructions may be present on one or more of the packaging, a label insert, containers present in the kits, and the like.
[0082] Although the foregoing invention has been described in some detail by way of illustration acid example for purposes of clarity of understanding, it is readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.

Claims (10)

1. A system comprising:
a plurality of devices wherein each said device comprises:
(i) at least one skin-piercing member configured to access physiological fluid beneath the skin surface;
(ii) a biosensor for measuring a characteristic of the accessed physiological fluid wherein said skin-piercing member is integrated with said biosensor;
and (iii) a physiological fluid transfer pathway extending from said at least one skin-piercing member to said biosensor; and a means for moving each of said plurality of devices in a manner that provides for angled penetration of the skin surface with said at least one skin-piercing member followed by removal of said at least one skin-piercing member from said skin surface
2. The system according to claim 1 wherein each said device comprises a planar configuration wherein said at least one skin-piercing member extends therefrom.
3. The system according to claim 2 wherein said at least one skin-piercing member extends substantially within the same plane as said planar configuration.
4. The system according to claim 3 wherein said planar device defines a biosensor having a test strip configuration and said at least one skin-piercing member extends from said test strip.
5. The system according to claim 2 wherein said at least one skin-piercing member extends in a direction substantially transverse to said planar device.
6. A system comprising:
a housing structure having a skin-facing portion and an aperture within said skin-facing portion;

a cartridge receivable within said housing structure and comprising a plurality of devices, each said device comprising a sensor means for measuring a characteristic of a physiological fluid, a skin-piercing element and a physiological fluid transfer pathway extending from said skin-piercing element and said sensor means;
means for moving said cartridge within said housing structure so as to operatively position each of said plurality of devices relative to said aperture; and a meter housed within said housing structure for applying signals to said sensor means for measuring a characteristic of physiological fluid and for receiving signals from said sensor means.
7. The system according to claim 6, wherein said means for moving said cartridge moves each of said devices relative to said aperture in a forward and then in a reverse direction.
8. The system according to claim 6, further comprising means for controlling the movement of and the timing of said movement of said cartridge.
9. The system according to claim 6, wherein said housing structure is configured to be worn on a limbic region.
10. The system according to claim 6, wherein said housing structure is configured to be worn about the waist.
CA002427843A 2002-05-09 2003-05-05 Devices and methods for accessing and analyzing physiological fluid Abandoned CA2427843A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/143,253 US7343188B2 (en) 2002-05-09 2002-05-09 Devices and methods for accessing and analyzing physiological fluid
US10/143,253 2002-05-09

Publications (1)

Publication Number Publication Date
CA2427843A1 true CA2427843A1 (en) 2003-11-09

Family

ID=29249849

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002427843A Abandoned CA2427843A1 (en) 2002-05-09 2003-05-05 Devices and methods for accessing and analyzing physiological fluid

Country Status (11)

Country Link
US (2) US7343188B2 (en)
EP (1) EP1360934B2 (en)
JP (1) JP2004000598A (en)
CN (1) CN1316247C (en)
AT (1) ATE347306T1 (en)
CA (1) CA2427843A1 (en)
DE (1) DE60310159T3 (en)
HK (1) HK1057158A1 (en)
IL (1) IL155342A0 (en)
SG (1) SG111106A1 (en)
TW (1) TW200406174A (en)

Families Citing this family (244)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9155496B2 (en) 1997-03-04 2015-10-13 Dexcom, Inc. Low oxygen in vivo analyte sensor
US7899511B2 (en) 2004-07-13 2011-03-01 Dexcom, Inc. Low oxygen in vivo analyte sensor
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US6949816B2 (en) 2003-04-21 2005-09-27 Motorola, Inc. Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same
US8465425B2 (en) 1998-04-30 2013-06-18 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8688188B2 (en) 1998-04-30 2014-04-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8974386B2 (en) 1998-04-30 2015-03-10 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US9066695B2 (en) 1998-04-30 2015-06-30 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8346337B2 (en) 1998-04-30 2013-01-01 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US6175752B1 (en) 1998-04-30 2001-01-16 Therasense, Inc. Analyte monitoring device and methods of use
US8480580B2 (en) 1998-04-30 2013-07-09 Abbott Diabetes Care Inc. Analyte monitoring device and methods of use
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US6560471B1 (en) 2001-01-02 2003-05-06 Therasense, Inc. Analyte monitoring device and methods of use
US7310543B2 (en) * 2001-03-26 2007-12-18 Kumetrix, Inc. Silicon microprobe with integrated biosensor
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
ATE497731T1 (en) 2001-06-12 2011-02-15 Pelikan Technologies Inc DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
CA2448905C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Blood sampling apparatus and method
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
DE10134650B4 (en) * 2001-07-20 2009-12-03 Roche Diagnostics Gmbh System for taking small amounts of body fluid
US7004928B2 (en) 2002-02-08 2006-02-28 Rosedale Medical, Inc. Autonomous, ambulatory analyte monitor or drug delivery device
US9247901B2 (en) 2003-08-22 2016-02-02 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US9282925B2 (en) 2002-02-12 2016-03-15 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8010174B2 (en) 2003-08-22 2011-08-30 Dexcom, Inc. Systems and methods for replacing signal artifacts in a glucose sensor data stream
US8260393B2 (en) 2003-07-25 2012-09-04 Dexcom, Inc. Systems and methods for replacing signal data artifacts in a glucose sensor data stream
DE10208575C1 (en) 2002-02-21 2003-08-14 Hartmann Paul Ag Blood analyzer device comprises needles, test media, analyzer and display, and has carrier turned with respect to main body, to position needle and test media
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8360992B2 (en) 2002-04-19 2013-01-29 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7892185B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7343188B2 (en) * 2002-05-09 2008-03-11 Lifescan, Inc. Devices and methods for accessing and analyzing physiological fluid
US7399401B2 (en) * 2002-10-09 2008-07-15 Abbott Diabetes Care, Inc. Methods for use in assessing a flow condition of a fluid
US7993108B2 (en) 2002-10-09 2011-08-09 Abbott Diabetes Care Inc. Variable volume, shape memory actuated insulin dispensing pump
EP1552146B1 (en) 2002-10-09 2011-04-20 Abbott Diabetes Care Inc. Fluid delivery device, system and method
US7727181B2 (en) 2002-10-09 2010-06-01 Abbott Diabetes Care Inc. Fluid delivery device with autocalibration
US20050049522A1 (en) * 2002-10-30 2005-03-03 Allen John J Method of lancing skin for the extraction of blood
US8672852B2 (en) 2002-12-13 2014-03-18 Intercure Ltd. Apparatus and method for beneficial modification of biorhythmic activity
US7815579B2 (en) * 2005-03-02 2010-10-19 Roche Diagnostics Operations, Inc. Dynamic integrated lancing test strip with sterility cover
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
US7214200B2 (en) * 2002-12-30 2007-05-08 Roche Diagnostics Operations, Inc. Integrated analytical test element
DE10302501A1 (en) * 2003-01-23 2004-08-05 Roche Diagnostics Gmbh Device and method for absorbing a body fluid for analysis purposes
US7052652B2 (en) 2003-03-24 2006-05-30 Rosedale Medical, Inc. Analyte concentration detection devices and methods
US20040193072A1 (en) * 2003-03-28 2004-09-30 Allen John J. Method of analyte measurement using integrated lance and strip
US7473264B2 (en) * 2003-03-28 2009-01-06 Lifescan, Inc. Integrated lance and strip for analyte measurement
EP1619994A4 (en) * 2003-04-16 2009-03-11 Univ Drexel Acoustic blood analyzer for assessing blood properties
US7679407B2 (en) * 2003-04-28 2010-03-16 Abbott Diabetes Care Inc. Method and apparatus for providing peak detection circuitry for data communication systems
ATE476137T1 (en) 2003-05-30 2010-08-15 Pelikan Technologies Inc METHOD AND DEVICE FOR INJECTING LIQUID
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1529488A1 (en) 2003-06-27 2005-05-11 Ehrfeld Mikrotechnik AG Device and method for sampling and analysing body fluids
US7220034B2 (en) * 2003-07-11 2007-05-22 Rudolph Technologies, Inc. Fiber optic darkfield ring light
US7761130B2 (en) 2003-07-25 2010-07-20 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423113B2 (en) 2003-07-25 2013-04-16 Dexcom, Inc. Systems and methods for processing sensor data
US7494465B2 (en) 2004-07-13 2009-02-24 Dexcom, Inc. Transcutaneous analyte sensor
US20190357827A1 (en) 2003-08-01 2019-11-28 Dexcom, Inc. Analyte sensor
US7774145B2 (en) 2003-08-01 2010-08-10 Dexcom, Inc. Transcutaneous analyte sensor
US8761856B2 (en) 2003-08-01 2014-06-24 Dexcom, Inc. System and methods for processing analyte sensor data
US8275437B2 (en) 2003-08-01 2012-09-25 Dexcom, Inc. Transcutaneous analyte sensor
US9135402B2 (en) 2007-12-17 2015-09-15 Dexcom, Inc. Systems and methods for processing sensor data
US7986986B2 (en) 2003-08-01 2011-07-26 Dexcom, Inc. System and methods for processing analyte sensor data
US8060173B2 (en) 2003-08-01 2011-11-15 Dexcom, Inc. System and methods for processing analyte sensor data
US8845536B2 (en) 2003-08-01 2014-09-30 Dexcom, Inc. Transcutaneous analyte sensor
US8886273B2 (en) 2003-08-01 2014-11-11 Dexcom, Inc. Analyte sensor
US20100168543A1 (en) 2003-08-01 2010-07-01 Dexcom, Inc. System and methods for processing analyte sensor data
US8160669B2 (en) 2003-08-01 2012-04-17 Dexcom, Inc. Transcutaneous analyte sensor
US7591801B2 (en) 2004-02-26 2009-09-22 Dexcom, Inc. Integrated delivery device for continuous glucose sensor
US8369919B2 (en) 2003-08-01 2013-02-05 Dexcom, Inc. Systems and methods for processing sensor data
US7223248B2 (en) * 2003-08-13 2007-05-29 Lifescan, Inc. Packaged medical device with a deployable dermal tissue penetration member
US7920906B2 (en) 2005-03-10 2011-04-05 Dexcom, Inc. System and methods for processing analyte sensor data for sensor calibration
US20140121989A1 (en) 2003-08-22 2014-05-01 Dexcom, Inc. Systems and methods for processing analyte sensor data
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
WO2005051170A2 (en) 2003-11-19 2005-06-09 Dexcom, Inc. Integrated receiver for continuous analyte sensor
US9247900B2 (en) 2004-07-13 2016-02-02 Dexcom, Inc. Analyte sensor
US11633133B2 (en) 2003-12-05 2023-04-25 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8423114B2 (en) 2006-10-04 2013-04-16 Dexcom, Inc. Dual electrode system for a continuous analyte sensor
US8287453B2 (en) 2003-12-05 2012-10-16 Dexcom, Inc. Analyte sensor
EP2239567B1 (en) 2003-12-05 2015-09-02 DexCom, Inc. Calibration techniques for a continuous analyte sensor
US8774886B2 (en) 2006-10-04 2014-07-08 Dexcom, Inc. Analyte sensor
US8364231B2 (en) 2006-10-04 2013-01-29 Dexcom, Inc. Analyte sensor
EP2329763B1 (en) 2003-12-09 2017-06-21 DexCom, Inc. Signal processing for continuous analyte sensor
JP4482318B2 (en) * 2003-12-15 2010-06-16 パナソニック株式会社 Puncture needle cartridge
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US20050187525A1 (en) * 2004-02-19 2005-08-25 Hilgers Michael E. Devices and methods for extracting bodily fluid
US8808228B2 (en) 2004-02-26 2014-08-19 Dexcom, Inc. Integrated medicament delivery device for use with continuous analyte sensor
PL1725168T3 (en) 2004-03-06 2016-10-31 Body fluid sampling device
US7819822B2 (en) 2004-03-06 2010-10-26 Roche Diagnostics Operations, Inc. Body fluid sampling device
JP4944770B2 (en) 2004-04-16 2012-06-06 ファセット・テクノロジーズ・エルエルシー Cap displacement mechanism for puncture device and multi-lancet cartridge
US8792955B2 (en) 2004-05-03 2014-07-29 Dexcom, Inc. Transcutaneous analyte sensor
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
GB2414734B (en) * 2004-06-01 2010-09-08 Rosti As Devices for retaining and presenting for use a plurality of components
US9775553B2 (en) 2004-06-03 2017-10-03 Sanofi-Aventis Deutschland Gmbh Method and apparatus for a fluid sampling device
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US20050284773A1 (en) * 2004-06-29 2005-12-29 Allen John J Method of preventing reuse in an analyte measuring system
US20060002817A1 (en) * 2004-06-30 2006-01-05 Sebastian Bohm Flow modulation devices
US7837633B2 (en) 2004-06-30 2010-11-23 Facet Technologies, Llc Lancing device and multi-lancet cartridge
US8343074B2 (en) 2004-06-30 2013-01-01 Lifescan Scotland Limited Fluid handling devices
US20060000709A1 (en) * 2004-06-30 2006-01-05 Sebastian Bohm Methods for modulation of flow in a flow pathway
US8452368B2 (en) 2004-07-13 2013-05-28 Dexcom, Inc. Transcutaneous analyte sensor
US7783333B2 (en) 2004-07-13 2010-08-24 Dexcom, Inc. Transcutaneous medical device with variable stiffness
US20060270922A1 (en) 2004-07-13 2006-11-30 Brauker James H Analyte sensor
US8565848B2 (en) 2004-07-13 2013-10-22 Dexcom, Inc. Transcutaneous analyte sensor
US7857760B2 (en) 2004-07-13 2010-12-28 Dexcom, Inc. Analyte sensor
US7310544B2 (en) 2004-07-13 2007-12-18 Dexcom, Inc. Methods and systems for inserting a transcutaneous analyte sensor
EP1671585A1 (en) * 2004-12-17 2006-06-21 F. Hoffmann-La Roche Ag Method of manufacturing a lancet element
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
US20060167382A1 (en) * 2004-12-30 2006-07-27 Ajay Deshmukh Method and apparatus for storing an analyte sampling and measurement device
US20090054811A1 (en) * 2004-12-30 2009-02-26 Dirk Boecker Method and apparatus for analyte measurement test time
US7545272B2 (en) 2005-02-08 2009-06-09 Therasense, Inc. RF tag on test strips, test strip vials and boxes
US7935063B2 (en) 2005-03-02 2011-05-03 Roche Diagnostics Operations, Inc. System and method for breaking a sterility seal to engage a lancet
US20090076360A1 (en) 2007-09-13 2009-03-19 Dexcom, Inc. Transcutaneous analyte sensor
US8133178B2 (en) 2006-02-22 2012-03-13 Dexcom, Inc. Analyte sensor
EP1863559A4 (en) 2005-03-21 2008-07-30 Abbott Diabetes Care Inc Method and system for providing integrated medication infusion and analyte monitoring system
EP1868491B1 (en) * 2005-03-24 2011-05-18 Roche Diagnostics GmbH Analyzing means with lancet and test element
EP1714613A1 (en) * 2005-04-22 2006-10-25 F. Hoffmann-La Roche Ag Analyzing means
US7768408B2 (en) 2005-05-17 2010-08-03 Abbott Diabetes Care Inc. Method and system for providing data management in data monitoring system
US20080194516A1 (en) * 2005-05-18 2008-08-14 Flanders Samuel J System for managing anti-coagulant infusions in patients
US20060281187A1 (en) 2005-06-13 2006-12-14 Rosedale Medical, Inc. Analyte detection devices and methods with hematocrit/volume correction and feedback control
CA2623589C (en) 2005-09-30 2014-07-22 Intuity Medical, Inc. Catalysts for body fluid sample extraction
US8801631B2 (en) 2005-09-30 2014-08-12 Intuity Medical, Inc. Devices and methods for facilitating fluid transport
US7756561B2 (en) * 2005-09-30 2010-07-13 Abbott Diabetes Care Inc. Method and apparatus for providing rechargeable power in data monitoring and management systems
US7583190B2 (en) 2005-10-31 2009-09-01 Abbott Diabetes Care Inc. Method and apparatus for providing data communication in data monitoring and management systems
US20080200838A1 (en) * 2005-11-28 2008-08-21 Daniel Goldberger Wearable, programmable automated blood testing system
GB2433926A (en) * 2005-12-22 2007-07-11 Lifescan Scotland Inc Container with RFID for storing calibration information
US9757061B2 (en) 2006-01-17 2017-09-12 Dexcom, Inc. Low oxygen in vivo analyte sensor
EP1991110B1 (en) 2006-03-09 2018-11-07 DexCom, Inc. Systems and methods for processing analyte sensor data
EP1839576A1 (en) * 2006-03-29 2007-10-03 F.Hoffmann-La Roche Ag Test system with test unit for analysing body fluids
US20080071158A1 (en) 2006-06-07 2008-03-20 Abbott Diabetes Care, Inc. Analyte monitoring system and method
US8579853B2 (en) 2006-10-31 2013-11-12 Abbott Diabetes Care Inc. Infusion devices and methods
EP2101654A4 (en) 2007-01-12 2013-03-06 Facet Technologies Llc Multi-lancet cartridge and lancing device
ATE534328T1 (en) * 2007-05-29 2011-12-15 Hoffmann La Roche FLEXIBLE LANCET IN A LANCET SYSTEM
EP2152350A4 (en) 2007-06-08 2013-03-27 Dexcom Inc Integrated medicament delivery device for use with continuous analyte sensor
US8961431B2 (en) * 2009-09-28 2015-02-24 Roche Diagnostics Operations, Inc. Body fluid lancing, acquiring, and testing cartridge design
US9186097B2 (en) * 2007-09-17 2015-11-17 Roche Diabetes Care, Inc. Body fluid lancing, acquiring, and testing cartridge design
EP2227132B1 (en) 2007-10-09 2023-03-08 DexCom, Inc. Integrated insulin delivery system with continuous glucose sensor
EP2050392B1 (en) * 2007-10-15 2012-09-05 Roche Diagnostics GmbH Lancet wheel
US8417312B2 (en) 2007-10-25 2013-04-09 Dexcom, Inc. Systems and methods for processing sensor data
US8290559B2 (en) 2007-12-17 2012-10-16 Dexcom, Inc. Systems and methods for processing sensor data
US20090209883A1 (en) * 2008-01-17 2009-08-20 Michael Higgins Tissue penetrating apparatus
US8229535B2 (en) 2008-02-21 2012-07-24 Dexcom, Inc. Systems and methods for blood glucose monitoring and alert delivery
JP2009225934A (en) * 2008-03-21 2009-10-08 Nitto Denko Corp Bodily fluid collecting circuit board and biosensor
US8396528B2 (en) 2008-03-25 2013-03-12 Dexcom, Inc. Analyte sensor
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
EP2113197A1 (en) 2008-05-03 2009-11-04 Roche Diagnostics GmbH Lancet wheel and method for manufacturing a lancet wheel
WO2009145920A1 (en) 2008-05-30 2009-12-03 Intuity Medical, Inc. Body fluid sampling device -- sampling site interface
JP5642066B2 (en) 2008-06-06 2014-12-17 インテュイティ メディカル インコーポレイテッド Method and apparatus for performing an assay to determine the presence or concentration of an analyte contained in a sample of body fluid
ES2907152T3 (en) 2008-06-06 2022-04-22 Intuity Medical Inc Blood glucose meter and method of operation
EP4227675A3 (en) 2008-09-19 2023-09-06 DexCom, Inc. Particle-containing membrane and particulate electrode for analyte sensors
BRPI0913784A2 (en) * 2008-09-30 2015-10-20 Menai Medical Technologies Ltd "sample measurement system, sampling plate, measuring device, adapter, data charger, sampling plate production method, continuous sheet production method, continuous sheet, apparatus, method for testing a medical condition, and , diagnostic kit to test a medical condition "
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
WO2010095442A1 (en) * 2009-02-18 2010-08-26 パナソニック株式会社 Puncture tool, device for measuring biological sample and system for measuring biological sample
EP2226008A1 (en) 2009-02-19 2010-09-08 Roche Diagnostics GmbH Method for producing an analytical magazine
EP2398388B1 (en) 2009-02-19 2020-04-08 Roche Diabetes Care GmbH Compact storage of auxiliary analytical devices in a cartridge
EP2226007A1 (en) 2009-02-19 2010-09-08 Roche Diagnostics GmbH Test element magazine with covered test fields
CN102405015B (en) * 2009-03-02 2017-01-18 第七感生物系统有限公司 Devices and methods for the analysis of an extractable medium
WO2012018486A2 (en) 2010-07-26 2012-02-09 Seventh Sense Biosystems, Inc. Rapid delivery and/or receiving of fluids
US9295417B2 (en) 2011-04-29 2016-03-29 Seventh Sense Biosystems, Inc. Systems and methods for collecting fluid from a subject
US20110172510A1 (en) * 2010-01-13 2011-07-14 Seventh Sense Biosystems, Inc. Rapid delivery and/or withdrawal of fluids
US9041541B2 (en) 2010-01-28 2015-05-26 Seventh Sense Biosystems, Inc. Monitoring or feedback systems and methods
US20110288389A9 (en) * 2009-03-02 2011-11-24 Seventh Sense Biosystems, Inc. Oxygen sensor
US9033898B2 (en) 2010-06-23 2015-05-19 Seventh Sense Biosystems, Inc. Sampling devices and methods involving relatively little pain
WO2010111660A1 (en) 2009-03-27 2010-09-30 Dexcom, Inc. Methods and systems for promoting glucose management
US8467972B2 (en) 2009-04-28 2013-06-18 Abbott Diabetes Care Inc. Closed loop blood glucose control algorithm analysis
JP2010271259A (en) * 2009-05-25 2010-12-02 Sysmex Corp Method, device, cartridge and kit for analyzing biological component
US9517027B2 (en) * 2009-07-10 2016-12-13 Facet Techonologies, Llc Advancement mechanism for cartridge-based devices
WO2011053787A2 (en) * 2009-10-30 2011-05-05 Seventh Sense Biosystems, Inc. Systems and methods for application to skin and control of actuation, delivery and/or perception thereof
EP2506768B1 (en) 2009-11-30 2016-07-06 Intuity Medical, Inc. Calibration material delivery devices and methods
GB201005359D0 (en) 2010-03-30 2010-05-12 Menai Medical Technologies Ltd Sampling plate
GB201005357D0 (en) 2010-03-30 2010-05-12 Menai Medical Technologies Ltd Sampling plate
US8965476B2 (en) * 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
EP2584964B1 (en) 2010-06-25 2021-08-04 Intuity Medical, Inc. Analyte monitoring devices
TW201212887A (en) * 2010-07-08 2012-04-01 Sanofi Aventis Deutschland Eliciting a blood sample
CN103068308B (en) 2010-07-16 2016-03-16 第七感生物系统有限公司 For the lower pressure environment of fluid conveying device
US20120039809A1 (en) 2010-08-13 2012-02-16 Seventh Sense Biosystems, Inc. Systems and techniques for monitoring subjects
CA2813041C (en) * 2010-10-06 2018-08-21 Natalie Ann Wisniewski Tissue-integrating sensors
US8808202B2 (en) 2010-11-09 2014-08-19 Seventh Sense Biosystems, Inc. Systems and interfaces for blood sampling
US9717452B2 (en) 2010-12-30 2017-08-01 Roche Diabetes Care, Inc. Handheld medical diagnostic devices with lancing speed control
US8852123B2 (en) 2010-12-30 2014-10-07 Roche Diagnostics Operations, Inc. Handheld medical diagnostic devices housing with sample transfer
US8158428B1 (en) 2010-12-30 2012-04-17 General Electric Company Methods, systems and apparatus for detecting material defects in combustors of combustion turbine engines
WO2012142502A2 (en) 2011-04-15 2012-10-18 Dexcom Inc. Advanced analyte sensor calibration and error detection
CN103874461B (en) 2011-04-29 2017-05-10 第七感生物系统有限公司 Devices for collection and/or manipulation of blood spots or other bodily fluids
US20130158468A1 (en) 2011-12-19 2013-06-20 Seventh Sense Biosystems, Inc. Delivering and/or receiving material with respect to a subject surface
AU2012249692A1 (en) 2011-04-29 2013-11-14 Seventh Sense Biosystems, Inc. Delivering and/or receiving fluids
EP2520225B1 (en) * 2011-05-06 2014-05-21 Roche Diagnostics GmbH Lancet
EP4339613A2 (en) 2011-08-03 2024-03-20 Intuity Medical, Inc. Body fluid sampling arrangement
JP2015506213A (en) * 2012-01-10 2015-03-02 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Capacitance sensor
DK2802260T3 (en) * 2012-01-10 2016-03-14 Sanofi Aventis Deutschland APPARATUS FOR REMOVING blood test
US9217723B2 (en) 2012-03-02 2015-12-22 Cilag Gmbh International Co-facial analytical test strip with stacked unidirectional contact pads
US9615779B2 (en) 2012-04-04 2017-04-11 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
WO2013156134A1 (en) * 2012-04-16 2013-10-24 Roche Diagnostics Gmbh Methods and structures for assembling lancet housing assemblies for handheld medical diagnostic devices
EP2874942B1 (en) * 2012-07-23 2018-09-05 Tasso, Inc. Methods and devices relating to open microfluidic channels
US9119529B2 (en) 2012-10-30 2015-09-01 Dexcom, Inc. Systems and methods for dynamically and intelligently monitoring a host's glycemic condition after an alert is triggered
US10375594B2 (en) * 2013-02-12 2019-08-06 Samsung Electronics Co., Ltd. Apparatus and method for generating an alert based on signal strength
JP2016522070A (en) 2013-06-21 2016-07-28 インテュイティ メディカル インコーポレイテッド Analyte monitoring system using audible feedback
US9933387B1 (en) 2014-09-07 2018-04-03 Biolinq, Inc. Miniaturized sub-nanoampere sensitivity low-noise potentiostat system
US10390707B2 (en) * 2015-05-11 2019-08-27 Samsung Electronics Co., Ltd Needle for biosensor and bio sensor including the same
US10154809B2 (en) 2015-06-24 2018-12-18 University Of Virginia Patent Foundation Test strip device and related methods thereof
US20170112533A1 (en) 2015-10-21 2017-04-27 Dexcom, Inc. Transcutaneous analyte sensors, applicators therefor, and associated methods
US10092207B1 (en) 2016-05-15 2018-10-09 Biolinq, Inc. Tissue-penetrating electrochemical sensor featuring a co-electrodeposited thin film comprised of polymer and bio-recognition element
US11045142B1 (en) 2017-04-29 2021-06-29 Biolinq, Inc. Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry
AU2018297208B2 (en) * 2017-07-06 2023-11-09 Becton, Dickinson And Company Biological fluid collection device
CA3077720A1 (en) 2017-10-24 2019-05-02 Dexcom, Inc. Pre-connected analyte sensors
US11331022B2 (en) 2017-10-24 2022-05-17 Dexcom, Inc. Pre-connected analyte sensors
US11291389B2 (en) * 2018-03-13 2022-04-05 Phc Holdings Corporation Sensor insertion device
USD875254S1 (en) 2018-06-08 2020-02-11 Biolinq, Inc. Intradermal biosensor
US10973444B1 (en) * 2018-07-31 2021-04-13 Jeffrey Michaels Standalone blood glucose meter
DK4048152T3 (en) 2020-07-29 2024-03-11 Biolinq Incorporated SYSTEM FOR CONTINUOUS ANALYTE MONITORING WITH MICRON NEEDLE ARRANGEMENT
US20220241984A1 (en) * 2021-01-29 2022-08-04 Battelle Memorial Institute Robot For Bio-Surveillance and Bio-Surveillance System
USD988160S1 (en) * 2021-03-16 2023-06-06 Biolinq Incorporated Wearable dermal sensor
CN116113454A (en) 2021-05-08 2023-05-12 比奥林股份有限公司 Continuous analyte monitoring device fault detection based on microneedle arrays
USD1013544S1 (en) * 2022-04-29 2024-02-06 Biolinq Incorporated Wearable sensor
USD996999S1 (en) * 2021-11-16 2023-08-29 Biolinq Incorporated Wearable sensor
USD1012744S1 (en) * 2022-05-16 2024-01-30 Biolinq Incorporated Wearable sensor with illuminated display

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3589557A (en) * 1969-04-03 1971-06-29 Miles Lab Slide dispenser
JPS5912135B2 (en) * 1977-09-28 1984-03-21 松下電器産業株式会社 enzyme electrode
DE2803345C2 (en) 1978-01-26 1980-02-14 Emil 7507 Pfinztal Eisinger Blood sampling device
US4187077A (en) * 1978-06-05 1980-02-05 Eastman Kodak Company Container with article positioning element for dispensing reagent coated slides to an automated analyzer
DE3278334D1 (en) * 1981-10-23 1988-05-19 Genetics Int Inc Sensor for components of a liquid mixture
US4734360A (en) * 1983-07-12 1988-03-29 Lifescan, Inc. Colorimetric ethanol analysis method and test device
US4900666A (en) * 1983-07-12 1990-02-13 Lifescan, Inc. Colorimetric ethanol analysis method and test device
US4787398A (en) * 1985-04-08 1988-11-29 Garid, Inc. Glucose medical monitoring system
US4627445A (en) * 1985-04-08 1986-12-09 Garid, Inc. Glucose medical monitoring system
IL80628A0 (en) * 1985-11-18 1987-02-27 Bajada Serge Apparatus for testing the sensory system in humans or animals
US4935346A (en) * 1986-08-13 1990-06-19 Lifescan, Inc. Minimum procedure system for the determination of analytes
US5059394A (en) * 1986-08-13 1991-10-22 Lifescan, Inc. Analytical device for the automated determination of analytes in fluids
US5049487A (en) * 1986-08-13 1991-09-17 Lifescan, Inc. Automated initiation of timing of reflectance readings
US4794926A (en) * 1986-11-24 1989-01-03 Invictus, Inc. Lancet cartridge
US4924879A (en) * 1988-10-07 1990-05-15 Brien Walter J O Blood lancet device
AU640162B2 (en) * 1989-08-28 1993-08-19 Lifescan, Inc. Blood separation and analyte detection techniques
US5306623A (en) * 1989-08-28 1994-04-26 Lifescan, Inc. Visual blood glucose concentration test strip
US5620863A (en) * 1989-08-28 1997-04-15 Lifescan, Inc. Blood glucose strip having reduced side reactions
JPH0820412B2 (en) * 1990-07-20 1996-03-04 松下電器産業株式会社 Quantitative analysis method and device using disposable sensor
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
GR1002549B (en) * 1992-05-12 1997-01-28 Lifescan Inc. Fluid conducting test strip with Transport Medium
DE69406560T2 (en) * 1993-02-03 1998-03-05 Mazda Motor Spark ignition internal combustion engine with supercharger
DE59410066D1 (en) * 1993-04-23 2002-04-11 Boehringer Mannheim Gmbh System for analyzing the contents of liquid samples
US5843691A (en) * 1993-05-15 1998-12-01 Lifescan, Inc. Visually-readable reagent test strip
DE4430023A1 (en) * 1994-08-24 1996-02-29 Boehringer Mannheim Gmbh Electrochemical sensor
US5515170A (en) * 1994-09-08 1996-05-07 Lifescan, Inc. Analyte detection device having a serpentine passageway for indicator strips
US5526120A (en) * 1994-09-08 1996-06-11 Lifescan, Inc. Test strip with an asymmetrical end insuring correct insertion for measuring
WO1996007908A1 (en) * 1994-09-08 1996-03-14 Lifescan, Inc. Optically readable strip for analyte detection having on-strip standard
US5575403A (en) * 1995-01-13 1996-11-19 Bayer Corporation Dispensing instrument for fluid monitoring sensors
FR2733745B1 (en) * 1995-05-02 1997-07-04 Asulab Sa IMPROVED APPARATUS FOR THE DISTRIBUTION OF SUCCESSIVE AREAS OF A CONSUMABLE BAND
US5510266A (en) * 1995-05-05 1996-04-23 Bayer Corporation Method and apparatus of handling multiple sensors in a glucose monitoring instrument system
US5972199A (en) * 1995-10-11 1999-10-26 E. Heller & Company Electrochemical analyte sensors using thermostable peroxidase
AU722471B2 (en) * 1995-10-17 2000-08-03 Lifescan, Inc. Blood glucose strip having reduced sensitivity to hematocrit
US5759010A (en) * 1995-11-06 1998-06-02 Jacobs; Merrit Nyles Sealed cartridge to improve chemistry stability of test elements
AUPN661995A0 (en) * 1995-11-16 1995-12-07 Memtec America Corporation Electrochemical cell 2
US5801057A (en) * 1996-03-22 1998-09-01 Smart; Wilson H. Microsampling device and method of construction
IL120587A (en) * 1996-04-04 2000-10-31 Lifescan Inc Reagent test strip for determination of blood glucose
US5660791A (en) * 1996-06-06 1997-08-26 Bayer Corporation Fluid testing sensor for use in dispensing instrument
US5846486A (en) * 1996-08-09 1998-12-08 Lifescan, Inc. Hollow frustum reagent test device
US5753429A (en) * 1996-08-09 1998-05-19 Lifescan, Inc. Analyte concentration measurement using a hollow frustum
US6071249A (en) * 1996-12-06 2000-06-06 Abbott Laboratories Method and apparatus for obtaining blood for diagnostic tests
US6036924A (en) * 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US5971941A (en) * 1997-12-04 1999-10-26 Hewlett-Packard Company Integrated system and method for sampling blood and analysis
DE19819407A1 (en) 1998-04-30 1999-11-11 Hendrik Priebs Cassette for disposable strip with test spots for e.g. blood sugar measurement
DE19840856B4 (en) 1998-09-07 2008-04-10 Roche Diagnostics Gmbh System for obtaining a body fluid, lancet magazine, lancet, lancet set, lancing device and method for removing a lancet from a lancet magazine and use of the system
US6475372B1 (en) * 2000-02-02 2002-11-05 Lifescan, Inc. Electrochemical methods and devices for use in the determination of hematocrit corrected analyte concentrations
US6193873B1 (en) 1999-06-15 2001-02-27 Lifescan, Inc. Sample detection to initiate timing of an electrochemical assay
AU6210199A (en) 1999-09-27 2001-04-30 Hypoguard Limited Test device
US6228100B1 (en) * 1999-10-25 2001-05-08 Steven Schraga Multi-use lancet device
US6716577B1 (en) * 2000-02-02 2004-04-06 Lifescan, Inc. Electrochemical test strip for use in analyte determination
ATE443862T1 (en) 2000-02-23 2009-10-15 Arkray Inc SENSOR CASSETTE, SENSOR FEEDER AND MEASURING INSTRUMENT
US6706159B2 (en) 2000-03-02 2004-03-16 Diabetes Diagnostics Combined lancet and electrochemical analyte-testing apparatus
US6612111B1 (en) 2000-03-27 2003-09-02 Lifescan, Inc. Method and device for sampling and analyzing interstitial fluid and whole blood samples
US6540675B2 (en) * 2000-06-27 2003-04-01 Rosedale Medical, Inc. Analyte monitor
GB0030929D0 (en) 2000-12-19 2001-01-31 Inverness Medical Ltd Analyte measurement
US6530892B1 (en) * 2001-03-07 2003-03-11 Helen V. Kelly Automatic skin puncturing system
US7310543B2 (en) * 2001-03-26 2007-12-18 Kumetrix, Inc. Silicon microprobe with integrated biosensor
US20030028125A1 (en) * 2001-08-06 2003-02-06 Yuzhakov Vadim V. Physiological sample collection devices and methods of using the same
US6952604B2 (en) * 2001-12-21 2005-10-04 Becton, Dickinson And Company Minimally-invasive system and method for monitoring analyte levels
US7343188B2 (en) * 2002-05-09 2008-03-11 Lifescan, Inc. Devices and methods for accessing and analyzing physiological fluid

Also Published As

Publication number Publication date
ATE347306T1 (en) 2006-12-15
CN1456887A (en) 2003-11-19
EP1360934A1 (en) 2003-11-12
US7343188B2 (en) 2008-03-11
CN1316247C (en) 2007-05-16
HK1057158A1 (en) 2004-03-19
SG111106A1 (en) 2005-05-30
DE60310159D1 (en) 2007-01-18
IL155342A0 (en) 2003-11-23
DE60310159T2 (en) 2007-09-20
DE60310159T3 (en) 2016-03-10
EP1360934B1 (en) 2006-12-06
EP1360934B2 (en) 2015-10-28
JP2004000598A (en) 2004-01-08
US20030212347A1 (en) 2003-11-13
TW200406174A (en) 2004-05-01
US20080009768A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
EP1360934B1 (en) Devices and methods for accessing and analyzing physiological fluid
AU2002247008B2 (en) Lancet device having capillary action
AU2001249100B2 (en) Combined lancet and electrochemical analyte-testing apparatus
EP1174078B1 (en) Hollow microneedle patch
CA2623589C (en) Catalysts for body fluid sample extraction
US20080200838A1 (en) Wearable, programmable automated blood testing system
US20080009767A1 (en) System for withdrawing small amounts of body fluid
AU2002247008A1 (en) Lancet device having capillary action
AU2001249100A1 (en) Combined lancet and electrochemical analyte-testing apparatus

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued